cb dualcar-nk19/70
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2023 (NCT05667155)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- CD70 antigenImmunity, passive
CD70 immunity, passive
- B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05842707 | Phase 1/Phase 2 (Phase 2) | Jan 18, 2023 | Huazhong University of Science and Technology |
| NCT05667155 | Phase 1 | Jan 1, 2023 | Zhejiang University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1